The AI Impact Summit 2026 has captured global attention this year as a major gathering where leaders from government, industry, and academia came together to ...
AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results